Gastrointestinal perforations in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs in Sweden: a nationwide cohort study

ObjectivesTo compare incidence rates of gastrointestinal (GI) perforations between patients with RA and the general population, and between patients treated with tumour necrosis factor inhibitors (TNFi) and non-TNFi biologics.MethodsIn this nationwide cohort study, a total of 63 532 patients with RA...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Rheumatic & musculoskeletal diseases open 2020-07, Vol.6 (2), p.e001201, Article 001201
Hauptverfasser:	Barbulescu, Andrei, Delcoigne, Bénédicte, Askling, Johan, Frisell, Thomas
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological products Clinical trials Cohort analysis Disease DMARDs (biologic) Drugs Emigration Epidemiology Life Sciences & Biomedicine Medicin och hälsovetenskap Monoclonal antibodies Patients Population Rheumatoid Arthritis Rheumatology Science & Technology Studies Surveillance Survival analysis Treatment Treatments Variables
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!